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ICG CLEARANCE IN ASSESSING CIRRHOTIC PATIENTS
WITH HEPATOCELLULAR CARCINOMA
FOR MAJOR HEPATIC RESECTION
ABSTRACT
Fan, S-T., LaL E.C.S., Lo, C-M., Ng, I.O.L. and Wong, J. (1995) Hospital mortality
ofmajor hepatectomyfor hepatocellular carcinoma associated with cirrhosis. Archives
of Surgery; 130:198-203
Objective: To deWne the safety of major hepatectomy for hepatocellular carcinoma
(HCC) associated with cirrhosis and the selection criteria for surgery in terms of
hospital mortality.
Design: Major hepatectomy for HCC in the presence of cirrhosis is considered to be
contraindicated by many surgeons because the reported mortality rate is high (26% to
50%). Previous workers recommended that only selected patients with Child’s A status
or indocyanine green (ICG) retention at 15 minutes of less than 10% unde..’go major
hepatectomy. A survery was made, therefore, of our patients with HCC and cirrhosis
undergoing major hepatectomy between 1989 and 1994.
Setting: A tertiary referral center.
Patients: The preoperative, intraoperative, and post-operative data of 54 patients with
cirrhosis who had major hepatectomy were compared with those of 25 patients with
underlying chronic active hepatitis and 22 patients with normal livers undergoing
major hepatectomy for HCC. The data had been prospectively collected.
Intervention: Major hepatectomy, defined as resection of two or more liver segments by
Goldsmith and Woodburn nomenclature, was performed on all the patients.
Main Outcome Measure: Hospital mortality, which was defined as death within the
same hospital admission for the hepatectomy.
Results: Preoperative liver function in patients with cirrhosis was worse than in those
with normal livers. The intraoperative blood loss was also higher (P=.01), but for
patients with cirrhosis, chronic active hepatitis, and normal livers, the hospital mortal-
ity rates (13%, 16%, and 14%, respectively) were similar. The hospital mortality rate
for patients with cirrhosis in the last 2 years of the study was only 5%. Patients with
cirrhosis could tolerate up to 10 L of blood loss and survive the major hepatectomy. By
discriminant analysis, an ICG retention of 14% at 15 minutes was cutoff level that
could maximally separate the patients with cirrhosis with and without mortality.
Conclusion: Major hepatectomy forHCC in the presence of cirrhosis is associated with
a mortality rate that is not different from the rate for patients with normal livers. AnICG
retention of 14% at 15 minutes would serve as a better selection criterion than the 10%
previously used.
(Arch Surg. 1995; 130: 198-203)
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PAPERDISCUSSION
Liver resection can now be carried out in many major
centres in order to treat hepatic diseases; the operative
mortality is less than 5%, if the associated liver paren-
chyma is normal. The existence of cirrhosis has been
traditionally considered a contraindication, particu-
larly for extensive hepatectomy because mortality and
morbidity rates are unacceptably high2. Cirrhotic
patients have metabolic, circulatory and coagulation
problems linked to the diminished capacity of the
diseased liver3’4.
In 54 cirrhotic patients treated by major liver resec-
tion. Dr Fan and his group confirmed data on some
patients, but raised the question of safety criteria for
extensive liver resection. Major hepatectomy wasHPB INTERNATIONAL 183
defined as resection oftwo ormore ofhepatic segments,
by the classification ofU.S.A. workers (Goldsmithand
Woodburne). Though the majority of their cirrhotic pa-
tients (89%, 48/54) underwent liver resection of more
than the right lobe, the hospital mortality was 13%, a
value compatible with data on patients with chronic
active hepatitis and normal livers (16% and 14%, re-
spectively). By discriminant analysis, and ICG reten-
tion of14% at 15 minutes (ICGR15) determined before
the surgery was the cut off level that could maximally
discriminate the presence or absence of hospital mor-
tality. The authors propose that this preoperative value
is a better risk parameter to predict posthepatectomy
liver failure than the previously used 10%.
Risk factors for post-hepatectomy liver failure in-
clude massive bleeding, extensive resection, ischemia
and postoperative infection, particularly for patients
with chronic liver diseases. With respect to intraope-
rativehaemorrhage in the present study, the non-surviv-
ing cirrhotic patients had a substantial blood loss
(11.0+2.5L, Mean+SE) of three times more than that
for the survivors (3.3+0.4L, p<0.02). Thus, massive
haemorrhage during hepatectomy can lead to hepatic
failure and a fatal outcome. However, the hemostatics
must be considered for this group, because even under
normal conditions of the associated liver parenchyma
there is a 1600ml ofblood loss requiring blood replace-
ment5. As a consequence, the majority of such patients
(86%, 19/22) are maintained on mechanical ventilation
following resection ofthe "normal" liver.
It is generally considered that there is no correlation
between conventional liver function tests and post-
hepatectomy mortality. Assessing functional reserve of
the liver is difficult, and methods range from a rela-
tively simple classification system to more complex
ones6. The ICG test, as a simple parameter, is consi-
dered to reflect the degree of hepatic dysfunction more
accurately7. The present report provides guidelines for
a safer, major lobectomy in cirrhotic patients. However,
the extent of the remnant liver parenchyma can
be significantly greater even under the same conditions
of lobectomy, because of a compensatory hypertrophy
due to thehugetumor to be resected. In this setting, since
the neoplastic tissue occupying the lobe to be resected
does not contain functioning hepatocytes, resection ofa
large tumor even by lobectomy does not unduly affect
the functionalvolume. In otlerwords, ablation ofmainly
the non-functioning liver mass by the major hepatec-
tomy should notworsen the preoperative total liver func-
tion, for instance, the preoperative ICG value. When
considering the relatively large mass lesions in the
present series, the authors could preoperatively estimate
the post-resectional functional volume of individual
livers. We emphasize that surgeons need to know the
critical functional reserve to sustain life after tumor
resection. For this purpose, Okamoto et al 8. Advo-
cate a combination use ofICG clearance test and liver
volumetry. Other investigators add a loading test
(maximal removal rate of ICG, R max) to quantify
the degree of hepatic functional reserve which is very
difficult to evaluate using the standard dye excretion
rate9. Further information is awaited regarding the
preoperative estimation of functional remnant vol-
ume in hepatic surgery.
Dr Fan and colleagues have provided information
which requires extended study on a large series of
major-hepatectomized cirrhotics. Risk factors using
the ICG clearance test in liver surgery should be given
due attention.
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